PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway
PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway have?
PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway has 37 citations in the OpenAlex counts ScholarIQ stores.
When was PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway published?
PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway has 2016 year in the ScholarIQ index.
What is the open-access status of PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway?
PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway has diamond oa status in the ScholarIQ index.
What is the DOI of PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway?
The DOI for PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway is on the source record.
What is the PMID of PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway?
The PMID for PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway is on the source record.
What is the OpenAlex record for PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway?
The OpenAlex for PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway is on the source record.